<DOC>
	<DOCNO>NCT02048995</DOCNO>
	<brief_summary>Objective . Bipolar Disorders ( BD ) major public health problem . The investigator still lack knowledge mechanism contribute BD . Hence treatment limit , clinical decision make less refine . Currently , investigator investigate effect midday bright light therapy treatment bipolar depression ( University Pittsburgh IRB approve protocol title Light Therapy Bipolar Disorder , IRB # : PRO09020546 ) . In study , investigator propose investigate possible biological mechanism might explain response light treatment depress bipolar patient .</brief_summary>
	<brief_title>Neural Visual Responses Light Bipolar Disorder : A Novel Putative Biomarker</brief_title>
	<detailed_description>The study goal understand response light therapy relate change vision , brain function improvement bipolar symptom . The aims investigate mood level plus eye brain response visual contrast stimulus healthy comparators ( HC ) bipolar depress patient . Study Design Methods . Overview . The investigator plan enroll 18-50 year old adult BD Type I II current episode major depression stable-dosed antimanic drug , age sex-matched HC - without mental disorder . Depressed patient BD assign randomly receive active light therapy v inactive comparator 6 week . The investigator examine response contrast stimuli measure visual evoke potential electro-retinography HC depress bipolar patient 6-weeks daily midday light therapy . The investigator assess repeat measure mood symptom level , attention circadian rhythm .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Ages 1850 year . DSMIV BD Type I II , current major depressive episode Stabledosed antidepressant drug 4 week concurrent antimanic drug . Controlled thyroid disease . Subjects preexist eye disease include specific exception describe Exclusion Criteria . Able provide inform consent . Stable minimum dose antimanic drug 4weeks . Stable unchanged psychotherapy 16 week . Permitted drug sleep low dos . Certain specific eye disease ( retinal disease , untreated cataract macular degeneration ) Photosensitizing drug phenothiazine ( chlorpromazine ) , antimalarial drug , melatonin hypericum . Acute psychosis ( DSMIV Criteria ) Rapid cycle past 1 year Alcohol substance abuse dependence past 6 month . Current symptom hypomania mania i.e . ManiaRatingScale=5 Recent history suicide attempt ( 3 month ) active suicidal ideation ( SIGHADS item H11=2 ) Treatment propranolol ( Inderal ) , exogenous melatonin , chronic NSAIDS .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Light Therapy</keyword>
	<keyword>Contrast Sensitivity</keyword>
	<keyword>Visual Evoked Potential</keyword>
	<keyword>Visual Neural Responses</keyword>
	<keyword>Biomarker</keyword>
</DOC>